Korean J Thorac Cardiovasc Surg.
2005 Oct;38(10):705-709.
Clinical Results of Pulmonary Resection for Hemoptysis of Inflammatory Lung Disease
- Affiliations
-
- 1Department of Thoracic and Cardiovascular Surgery, Chonbuk National University Medical School, Jeonju, Korea. yhseo@chonbuk.ac.kr
Abstract
-
BACKGROUND: To assess the outcome of pulmonary resection in the management of hemoptysis caused by benign inflammatory lung disease.
MATERIAL AND METHOD: A longitudinal cohort study of 45 consecutive patients who were presented with hemoptysis and were treated with pulmonary resection from January 1995 to May 2004. The predictive preoperative risk factors of morbidity and recurrence of hemoptysis were analyzed. The mean age of the patients was 47.1 years. The mean follow-up was 35+/-34 months.
RESULT: The overall hospital mortality rate was 4.4% (2/45). Postoperative complications occurred in 8 patients (18.6%). Complications were more common in patients who received blood transfusion than non-transfused patients (p=0.002). Patients with tuberculous destroyed lung disease had more amount of preoperative hemoptysis (p=0.002), more probability of transfusion (p=0.001), more probability of undergoing pneumonectomy (p=0.039) and more probability of postoperative morbidity. Patients of undergoing pneumonectomy had more probability of reoperation due to postoperative bleeding (p=0.047). Hemoptysis recurred in five patients but three had been subsided and two sustained during follow-up. A latter two patients had been prescribed with antituberculosis medication due to relapse of tuberculosis.
CONCLUSION
A tuberculous destroyed lung disease has a higher rate of postoperative morbidity than other inflammatory lung diseases. A pneumonectomy in patients of inflammatory lung disease should be performed with great caution especially because of postoperative bleeding. Future study with longer and larger follow-up might show the reasons of recurrence of hemoptysis.